Pharmaceutical virtue

Emily Martin

    Research output: Contribution to journalArticle

    Abstract

    In the early history of psychopharmacology, the prospect of developing technologically sophisticated drugs to alleviate human ills was surrounded with a fervor that could be described as religious. This paper explores the subsequent history of the development of psychopharmacological agents, focusing on the ambivalent position of both the industry and its employees. Based on interviews with retired pharmaceutical employees who were active in the industry in the 1950s and 1960s when the major breakthroughs were made in the development of MAOIs and SSRIs, the paper explores the initial development of educational materials for use in sales campaigns. In addition, based on interviews with current employees in pharmaceutical sales and marketing, the paper describes the complex perspective of contemporary pharmaceutical employees who must live surrounded by the growing public vilification of the industry as rapacious and profit hungry and yet find ways to make their jobs meaningful and dignified. The paper will contribute to the understudied problem of how individuals function in positions that require them to be part of processes that on one description constitute a social evil, but on another, constitute a social good.

    Original languageEnglish (US)
    Pages (from-to)157-174
    Number of pages18
    JournalCulture, Medicine and Psychiatry
    Volume30
    Issue number2
    DOIs
    StatePublished - Jun 2006

    Fingerprint

    pharmaceutical
    employee
    Industry
    Pharmaceutical Preparations
    sales
    industry
    History
    Interviews
    Psychopharmacology
    history
    interview
    Marketing
    profit
    marketing
    campaign
    drug
    Employees
    Pharmaceuticals

    Keywords

    • Pharmaceutical industry
    • Pharmaceutical marketing
    • Pharmaceutical salesmen
    • Psychopharmacology

    ASJC Scopus subject areas

    • Psychiatry and Mental health
    • Social Sciences(all)
    • Social Sciences (miscellaneous)
    • Anthropology

    Cite this

    Pharmaceutical virtue. / Martin, Emily.

    In: Culture, Medicine and Psychiatry, Vol. 30, No. 2, 06.2006, p. 157-174.

    Research output: Contribution to journalArticle

    Martin, Emily. / Pharmaceutical virtue. In: Culture, Medicine and Psychiatry. 2006 ; Vol. 30, No. 2. pp. 157-174.
    @article{334ace00e0884bfd987d67963fb68b55,
    title = "Pharmaceutical virtue",
    abstract = "In the early history of psychopharmacology, the prospect of developing technologically sophisticated drugs to alleviate human ills was surrounded with a fervor that could be described as religious. This paper explores the subsequent history of the development of psychopharmacological agents, focusing on the ambivalent position of both the industry and its employees. Based on interviews with retired pharmaceutical employees who were active in the industry in the 1950s and 1960s when the major breakthroughs were made in the development of MAOIs and SSRIs, the paper explores the initial development of educational materials for use in sales campaigns. In addition, based on interviews with current employees in pharmaceutical sales and marketing, the paper describes the complex perspective of contemporary pharmaceutical employees who must live surrounded by the growing public vilification of the industry as rapacious and profit hungry and yet find ways to make their jobs meaningful and dignified. The paper will contribute to the understudied problem of how individuals function in positions that require them to be part of processes that on one description constitute a social evil, but on another, constitute a social good.",
    keywords = "Pharmaceutical industry, Pharmaceutical marketing, Pharmaceutical salesmen, Psychopharmacology",
    author = "Emily Martin",
    year = "2006",
    month = "6",
    doi = "10.1007/s11013-006-9014-2",
    language = "English (US)",
    volume = "30",
    pages = "157--174",
    journal = "Culture, Medicine and Psychiatry",
    issn = "0165-005X",
    publisher = "Springer New York",
    number = "2",

    }

    TY - JOUR

    T1 - Pharmaceutical virtue

    AU - Martin, Emily

    PY - 2006/6

    Y1 - 2006/6

    N2 - In the early history of psychopharmacology, the prospect of developing technologically sophisticated drugs to alleviate human ills was surrounded with a fervor that could be described as religious. This paper explores the subsequent history of the development of psychopharmacological agents, focusing on the ambivalent position of both the industry and its employees. Based on interviews with retired pharmaceutical employees who were active in the industry in the 1950s and 1960s when the major breakthroughs were made in the development of MAOIs and SSRIs, the paper explores the initial development of educational materials for use in sales campaigns. In addition, based on interviews with current employees in pharmaceutical sales and marketing, the paper describes the complex perspective of contemporary pharmaceutical employees who must live surrounded by the growing public vilification of the industry as rapacious and profit hungry and yet find ways to make their jobs meaningful and dignified. The paper will contribute to the understudied problem of how individuals function in positions that require them to be part of processes that on one description constitute a social evil, but on another, constitute a social good.

    AB - In the early history of psychopharmacology, the prospect of developing technologically sophisticated drugs to alleviate human ills was surrounded with a fervor that could be described as religious. This paper explores the subsequent history of the development of psychopharmacological agents, focusing on the ambivalent position of both the industry and its employees. Based on interviews with retired pharmaceutical employees who were active in the industry in the 1950s and 1960s when the major breakthroughs were made in the development of MAOIs and SSRIs, the paper explores the initial development of educational materials for use in sales campaigns. In addition, based on interviews with current employees in pharmaceutical sales and marketing, the paper describes the complex perspective of contemporary pharmaceutical employees who must live surrounded by the growing public vilification of the industry as rapacious and profit hungry and yet find ways to make their jobs meaningful and dignified. The paper will contribute to the understudied problem of how individuals function in positions that require them to be part of processes that on one description constitute a social evil, but on another, constitute a social good.

    KW - Pharmaceutical industry

    KW - Pharmaceutical marketing

    KW - Pharmaceutical salesmen

    KW - Psychopharmacology

    UR - http://www.scopus.com/inward/record.url?scp=33748324619&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=33748324619&partnerID=8YFLogxK

    U2 - 10.1007/s11013-006-9014-2

    DO - 10.1007/s11013-006-9014-2

    M3 - Article

    VL - 30

    SP - 157

    EP - 174

    JO - Culture, Medicine and Psychiatry

    JF - Culture, Medicine and Psychiatry

    SN - 0165-005X

    IS - 2

    ER -